BioInvent International AB (publ) (STO:BINV)
4.300
-1.130 (-20.81%)
Nov 2, 2026, 5:29 PM CET
STO:BINV Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -486.85 | -332.86 | -429.38 | -330.3 | -42.5 | -278.44 |
Depreciation & Amortization | 18.12 | 19.87 | 19.3 | 16.76 | 14.72 | 14.61 |
Stock-Based Compensation | 4.7 | 4.72 | 5.46 | 2.95 | 1.79 | 1.14 |
Other Operating Activities | 4.53 | 10.88 | 16.57 | -20.95 | -8.46 | -0.18 |
Change in Accounts Receivable | 32.44 | 32.44 | -12.37 | 2.35 | -38.73 | 23.35 |
Change in Inventory | -1.33 | -1.33 | 0.88 | -0.34 | 5.34 | -12.77 |
Change in Other Net Operating Assets | -20.48 | 18.52 | 19.06 | -12.16 | 26.62 | 6.44 |
Operating Cash Flow | -448.86 | -247.76 | -380.47 | -341.69 | -41.23 | -245.84 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -2.71 | -7.26 | -10.03 | -13.3 | -12.38 | -13.26 |
Investment in Securities | 207 | 187.39 | 574.38 | 72.99 | -616.47 | -454.28 |
Investing Cash Flow | 204.29 | 180.13 | 564.35 | 59.68 | -628.85 | -467.54 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -8.99 | -8.46 | -7.82 | -6.36 | -5.92 |
Lease Payments | -8.86 | -8.99 | -8.46 | -7.82 | -6.36 | -5.92 |
Net Debt Issued (Repaid) | -8.86 | -8.99 | -8.46 | -7.82 | -6.36 | -5.92 |
Issuance of Common Stock | - | - | - | 30.96 | 279.85 | 900.79 |
Financing Cash Flow | -8.86 | -8.99 | -8.46 | 23.14 | 273.49 | 894.87 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | -5.28 | -2.04 | -0.14 | 3.37 | 0.88 | - |
Net Cash Flow | -258.71 | -78.66 | 175.28 | -255.5 | -395.71 | 181.49 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -451.58 | -255.02 | -390.5 | -355 | -53.6 | -259.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -1129.45% | -112.59% | -873.88% | -496.77% | -16.44% | -1336.68% |
Free Cash Flow Per Share | -6.86 | -3.88 | -5.93 | -5.40 | -0.87 | -4.78 |
Levered Free Cash Flow | -280.65 | -152.3 | -272.84 | -235.5 | -34.03 | -156.68 |
Unlevered Free Cash Flow | -280.4 | -152.05 | -272.49 | -235.1 | -33.63 | -156.36 |
Free Cash Flow After Leases | -460.44 | -264 | -398.96 | -362.82 | -59.97 | -265.03 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.4 | 0.4 | 0.56 | 0.64 | 0.65 | 0.52 |
Cash Income Tax Paid | 0.53 | 0.18 | 0.11 | 0.09 | - | - |
Change in Working Capital | 10.63 | 49.63 | 7.57 | -10.15 | -6.78 | 17.03 |